HealthCert Blog

In this month’s dermatology review on acne, there were certain trends such as the use of light and lasers, revisiting well-established treatments such as oral antibiotics and spironolactone as well as those studies supporting new treatments. Several new topical treatments are now or soon to be available. The supporting studies are included for topical dapsone gel, a new fixed combination formulation of adapalene and benzoyl peroxide and the new biophotonic gel. The selected papers begin with acne pathogenesis.

Featured in this issue:

• Skin mTOR and Fox01 expression and serum IGF-1, and relationships with diet, in acne vulgaris
• Recent research in P. acnes strain diversity
• Guidelines of care for acne vulgaris
• Oral spironolactone for acne vulgaris in women
• Oral antibacterials for acne vulgaris
• 7.5% dapsone gel in acne vulgaris
• 0.3% adapalene combination for inflammatory acne vulgaris
• Chromophore gel-assisted blue-light phototherapy for acne
• Topical minocycline foam for moderate-to-severe acne vulgaris
• Changes in topical erythromycin and clindamycin use for acne vulgaris

Click here to download the full paper 

Interested in General Dermatology?

The HealthCert Professional Diploma of General Dermatology will teach you how to manage all major dermatological conditions in primary care. The courses are university quality-assured, CPD-accredited and count towards multiple Master degree pathways and clinical attachment programs in Australia and overseas. The program is delivered online.